Allogene Therapeutics, Inc. (ALLO)
1.48
+0.06
(+4.23%)
USD |
NASDAQ |
Dec 10, 16:00
1.47
-0.01
(-0.68%)
After-Hours: 20:00
Allogene Therapeutics Total Assets (Quarterly): 439.77M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Akero Therapeutics, Inc. | 1.006B |
| ANI Pharmaceuticals, Inc. | 1.408B |
| AIM ImmunoTech, Inc. | 5.494M |
| Protalix Biotherapeutics, Inc. | 82.26M |
| Armata Pharmaceuticals, Inc. | 89.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 124.44M |
| Shareholders Equity (Quarterly) | 315.33M |
| Debt to Equity Ratio | 0.27 |
| Current Ratio | 8.190 |
| Net Debt Paydown Yield | 0.66% |